UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 448

Sortiert nach

Prognosis of microsatellite instability and/or mismatch repair deficiency stage III colon cancer patients after disease recurrence following adjuvant treatment: results of an ACCENT pooled analysis of seven studies

Annals of oncology, 2019-09, Vol.30 (9), p.1466-1471

2019

Link zum Volltext

Verfügbarkeit prüfen

Long-term efficacy and safety of addition of carboplatin with or without veliparib to standard neoadjuvant chemotherapy in triple-negative breast cancer: 4-year follow-up data from BrighTNess, a randomized phase III trial

Annals of oncology, 2022-04, Vol.33 (4), p.384-394

2022

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Outcomes of Invasive Ipsilateral Breast Tumor Recurrences After Lumpectomy in NSABP B-17 and B-24 Randomized Clinical Trials for DCIS

JNCI : Journal of the National Cancer Institute, 2011-03, Vol.103 (6), p.478-488

2011

Link zum Volltext

Verfügbarkeit prüfen

Five Versus More Than Five Years of Tamoxifen for Lymph Node-Negative Breast Cancer: Updated Findings From the National Surgical Adjuvant Breast and Bowel Project B-14 Randomized Trial

JNCI : Journal of the National Cancer Institute, 2001-05, Vol.93 (9), p.684-690

2001

Link zum Volltext

Verfügbarkeit prüfen

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer

Journal of clinical oncology, 2023-04, Vol.41 (10), p.1795-1808

2023

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of the change of outcomes over a 10-year period in patients with stage III colon cancer: pooled analysis of 6501 patients treated with fluorouracil, leucovorin, and oxaliplatin in the ACCENT database

Annals of oncology, 2020-04, Vol.31 (4), p.480-486

2020

Link zum Volltext

Verfügbarkeit prüfen

Real-World Performance of HER2 Testing—National Surgical Adjuvant Breast and Bowel Project Experience

JNCI : Journal of the National Cancer Institute, 2002-06, Vol.94 (11), p.852-854

2002

Link zum Volltext

Verfügbarkeit prüfen

Two or three year disease-free survival (DFS) as a primary end-point in stage III adjuvant colon cancer trials with fluoropyrimidines with or without oxaliplatin or irinotecan: Data from 12,676 patients from MOSAIC, X-ACT, PETACC-3, C-06, C-07 and C89803

European journal of cancer (1990), 2011-05, Vol.47 (7), p.990-996

2011

Link zum Volltext

Verfügbarkeit prüfen

Preoperative Chemotherapy in Patients With Operable Breast Cancer: Nine-Year Results From National Surgical Adjuvant Breast and Bowel Project B-18

Journal of the National Cancer Institute. Monographs, 2001, Vol.2001 (30), p.96-102

2001

Link zum Volltext

Verfügbarkeit prüfen

GeparDouze/NSABP B-59: A randomized double-blind phase III clinical trial of neoadjuvant chemotherapy with atezolizumab or placebo in patients with triple negative breast cancer (TNBC) followed by adjuvant atezolizumab or placebo

Annals of oncology, 2019-05, Vol.30, p.iii38-iii38

2019

Link zum Volltext

Verfügbarkeit prüfen

Abstract ML1: The Contribution of NSABP Clinical Trials to the Management of Early Breast Cancer

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.ML1-ML1

Wolmark, N

2016

Link zum Volltext

Verfügbarkeit prüfen

Tamoxifen and Chemotherapy for Lymph Node-Negative, Estrogen Receptor-Positive Breast Cancer

JNCI : Journal of the National Cancer Institute, 1997-11, Vol.89 (22), p.1673-1682

1997

Link zum Volltext

Verfügbarkeit prüfen

Weekly paclitaxel and concurrent pazopanib following doxorubicin and cyclophosphamide as neoadjuvant therapy for HER-negative locally advanced breast cancer: NSABP Foundation FB-6, a phase II study

Breast cancer research and treatment, 2015-01, Vol.149 (1), p.163-169

2015

Link zum Volltext

Verfügbarkeit prüfen

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer

Journal of clinical oncology, 1998-08, Vol.16 (8), p.2672-2685

1998

Link zum Volltext

Verfügbarkeit prüfen

Randomized trial of postoperative Adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum : National Surgical Adjuvant breast and Bowel Project Protocol R-02

JNCI : Journal of the National Cancer Institute, 2000-03, Vol.92 (5), p.388-396

2000

Link zum Volltext

Verfügbarkeit prüfen

Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18

Journal of clinical oncology, 1997-07, Vol.15 (7), p.2483-2493

1997

Link zum Volltext

Verfügbarkeit prüfen

Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17

Journal of clinical oncology, 1998-02, Vol.16 (2), p.441-452

1998

Link zum Volltext

Verfügbarkeit prüfen

Tamoxifen and Chemotherapy for Axillary Node-Negative, Estrogen Receptor–Negative Breast Cancer: Findings From National Surgical Adjuvant Breast and Bowel Project B-23

Journal of clinical oncology, 2001-02, Vol.19 (4), p.931-942

2001

Link zum Volltext

Verfügbarkeit prüfen

Estrogen receptor status of primary breast cancer is predictive of estrogen receptor status of contralateral breast cancer

JNCI : Journal of the National Cancer Institute, 2004-04, Vol.96 (7), p.516-523

2004

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Axillary Lymph Node–Negative, Estrogen Receptor–Negative Breast Cancer: Updated Findings From National Surgical Adjuvant Breast and Bowel Project Clinical Trials

JNCI : Journal of the National Cancer Institute, 2004-12, Vol.96 (24), p.1823-1831

2004

Link zum Volltext

Verfügbarkeit prüfen

Effect of extended adjuvant endocrine therapy with letrozole (L) in postmenopausal women with hormone-receptor (+) breast cancer after prior adjuvant therapy with an aromatase inhibitor (AI): NRG Oncology/NSABP B-42

Breast (Edinburgh), 2017-03, Vol.32, p.S25-S26

2017

Link zum Volltext

Verfügbarkeit prüfen

An Update of the Credentialing Process for the NRG Oncology NSABP B-51 / RTOG 1304 Phase 3 Randomized Clinical Trial

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.E570-E570

2015

Link zum Volltext

Verfügbarkeit prüfen

The Impact of Radiation Therapy on Lymphedema Risk and the Agreement Between Subjective and Objective Lymphedema Measures: NSABP B-32 Secondary Data Analysis

International journal of radiation oncology, biology, physics, 2014-09, Vol.90 (1), p.S4-S5

2014

Link zum Volltext

Verfügbarkeit prüfen

Lower-category benign breast disease and the risk of invasive breast cancer

JNCI : Journal of the National Cancer Institute, 2004-04, Vol.96 (8), p.616-620

2004

Link zum Volltext

Verfügbarkeit prüfen

Prognosis and Treatment of Patients With Breast Tumors of One Centimeter or Less and Negative Axillary Lymph Nodes

JNCI : Journal of the National Cancer Institute, 2001-01, Vol.93 (2), p.112-120

2001

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 448

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(417)
Mit Volltextzugriff
(407)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(209)
Female
(193)
Life Sciences & Biomedicine
(190)
Science & Technology
(190)
Middle Aged
(135)
Biological And Medical Sciences
(128)
Oncology
(128)
Medical Sciences
(125)
Tumors
(96)
Breast Neoplasms - Drug Therapy
(89)
Breast Neoplasms - Pathology
(81)
Aged
(76)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(72)
Breast Neoplasms - Surgery
(67)
Breast Cancer
(63)
Adult
(60)
Chemotherapy, Adjuvant
(56)
Chemotherapy
(55)
Disease-Free Survival
(53)
Fluorouracil - Administration & Dosage
(53)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prognosis of microsatellite instability and/or mismatch repair deficiency stage III colon cancer patients after disease recurrence following adjuvant treatment: results of an ACCENT pooled analysis of seven studies

Long-term efficacy and safety of addition of carboplatin with or without veliparib to standard neoadjuvant chemotherapy in triple-negative breast cancer: 4-year follow-up data from BrighTNess, a randomized phase III trial

Long-Term Outcomes of Invasive Ipsilateral Breast Tumor Recurrences After Lumpectomy in NSABP B-17 and B-24 Randomized Clinical Trials for DCIS

Five Versus More Than Five Years of Tamoxifen for Lymph Node-Negative Breast Cancer: Updated Findings From the National Surgical Adjuvant Breast and Bowel Project B-14 Randomized Trial

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer

Evaluation of the change of outcomes over a 10-year period in patients with stage III colon cancer: pooled analysis of 6501 patients treated with fluorouracil, leucovorin, and oxaliplatin in the ACCENT database

Real-World Performance of HER2 Testing—National Surgical Adjuvant Breast and Bowel Project Experience

Two or three year disease-free survival (DFS) as a primary end-point in stage III adjuvant colon cancer trials with fluoropyrimidines with or without oxaliplatin or irinotecan: Data from 12,676 patients from MOSAIC, X-ACT, PETACC-3, C-06, C-07 and C89803

Preoperative Chemotherapy in Patients With Operable Breast Cancer: Nine-Year Results From National Surgical Adjuvant Breast and Bowel Project B-18

GeparDouze/NSABP B-59: A randomized double-blind phase III clinical trial of neoadjuvant chemotherapy with atezolizumab or placebo in patients with triple negative breast cancer (TNBC) followed by adjuvant atezolizumab or placebo

Abstract ML1: The Contribution of NSABP Clinical Trials to the Management of Early Breast Cancer

Tamoxifen and Chemotherapy for Lymph Node-Negative, Estrogen Receptor-Positive Breast Cancer

Weekly paclitaxel and concurrent pazopanib following doxorubicin and cyclophosphamide as neoadjuvant therapy for HER-negative locally advanced breast cancer: NSABP Foundation FB-6, a phase II study

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer

Randomized trial of postoperative Adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum : National Surgical Adjuvant breast and Bowel Project Protocol R-02

Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18

Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17

Tamoxifen and Chemotherapy for Axillary Node-Negative, Estrogen Receptor–Negative Breast Cancer: Findings From National Surgical Adjuvant Breast and Bowel Project B-23

Estrogen receptor status of primary breast cancer is predictive of estrogen receptor status of contralateral breast cancer

Treatment of Axillary Lymph Node–Negative, Estrogen Receptor–Negative Breast Cancer: Updated Findings From National Surgical Adjuvant Breast and Bowel Project Clinical Trials

Effect of extended adjuvant endocrine therapy with letrozole (L) in postmenopausal women with hormone-receptor (+) breast cancer after prior adjuvant therapy with an aromatase inhibitor (AI): NRG Oncology/NSABP B-42

An Update of the Credentialing Process for the NRG Oncology NSABP B-51 / RTOG 1304 Phase 3 Randomized Clinical Trial

The Impact of Radiation Therapy on Lymphedema Risk and the Agreement Between Subjective and Objective Lymphedema Measures: NSABP B-32 Secondary Data Analysis

Lower-category benign breast disease and the risk of invasive breast cancer

Prognosis and Treatment of Patients With Breast Tumors of One Centimeter or Less and Negative Axillary Lymph Nodes

Suchergebnisse filtern